Cargando…
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study
Propranolol, a lipophilic nonselective β-blocker, has recently been reported to be the treatment of choice for select types of infantile hemangiomas (IHs). Atenolol is a hydrophilic, selective β(1)-blocker and therefore may be not associated with side effects attributable to β(2)-adrenergic receptor...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998480/ https://www.ncbi.nlm.nih.gov/pubmed/27310994 http://dx.doi.org/10.1097/MD.0000000000003908 |